Predictive Significance of High-Sensitivity C-Reactive Protein Combined with Homocysteine for Coronary Heart Disease

Changhe Liu1, Na Hua2, Yanli Zhang3

  • 1Department of Cardiology, Affiliated Zhongshan Hospital of Dalian University, Dalian 116001, China.

Insights

Biomarkers like high-sensitivity C-reactive protein (hs-CRP) and homocysteine (Hcy) can help predict coronary heart disease (CHD) in patients with anxiety disorders. Combined detection of hs-CRP and Hcy shows significant predictive value for CHD in this population.

Area of Science:

  • Cardiology
  • Psychiatry
  • Biomarker Research

Background:

  • Limited research exists on biomarkers for predicting coronary heart disease (CHD) in patients with anxiety disorders.
  • Anxiety disorders are increasingly recognized as a comorbidity impacting cardiovascular health.
  • Understanding predictive biomarkers is crucial for early intervention and management.

Purpose of the Study:

  • To identify risk factors for CHD in patients with anxiety disorders.
  • To evaluate the predictive value of common peripheral blood indicators, specifically high-sensitivity C-reactive protein (hs-CRP) and homocysteine (Hcy).
  • To explore the combined diagnostic efficacy of hs-CRP and Hcy for CHD in anxious patients.

Main Methods:

  • 153 hospitalized patients with chest pain and anxiety (Hamilton Anxiety Scale score > 14) were recruited.
  • Patients were categorized into an anxiety disorder with CHD group (n=64) and a simple anxiety disorder group (n=89) based on coronary angiography.
  • Peripheral blood levels of IL-6, hs-CRP, Hcy, and other markers were compared; logistic regression and ROC curve analyses were performed.

Main Results:

  • Interleukin-6 (IL-6), hs-CRP, and Hcy levels were significantly elevated in the CHD with anxiety group compared to the simple anxiety group.
  • IL-6, hs-CRP, and Hcy were identified as independent risk factors for CHD in patients with anxiety disorders.
  • Combined detection of hs-CRP and Hcy demonstrated superior predictive value for CHD in anxious patients compared to single markers, with a significantly larger area under the curve (AUC).

Conclusions:

  • Interleukin-6 (IL-6), hs-CRP, and Hcy are associated with the presence of CHD in patients experiencing anxiety disorders.
  • The combined assessment of serum hs-CRP and Hcy levels offers high clinical predictive value for identifying CHD in patients with anxiety disorders.
  • This finding supports the utility of these biomarkers in risk stratification for comorbid CHD and anxiety.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
195
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
66
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47
Stress and Mental Health01:30

Stress and Mental Health

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
202
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31